PANACEA BIOTEC
|
PANACEA BIOTEC Last 5 Year Balance Sheet History
[Consolidated]
Mar2024 | Mar2023 | Mar2022 | Mar2021 | Mar2020 | |
---|---|---|---|---|---|
EQUITY AND LIABILITIES | |||||
Share Capital | ₹6.13 Cr | ₹6.13 Cr | ₹6.13 Cr | ₹6.13 Cr | ₹6.13 Cr |
Equity - Authorised | ₹13 Cr | ₹13 Cr | ₹13 Cr | ₹13 Cr | ₹13 Cr |
Equity - Issued | ₹6.13 Cr | ₹6.13 Cr | ₹6.13 Cr | ₹6.13 Cr | ₹6.13 Cr |
Equity Paid Up | ₹6.13 Cr | ₹6.13 Cr | ₹6.13 Cr | ₹6.13 Cr | ₹6.13 Cr |
Equity Shares Forfeited | - | - | - | - | - |
Adjustments to Equity | - | - | - | - | - |
Preference Capital Paid Up | - | - | - | - | - |
Face Value | ₹1.00 | ₹1.00 | ₹1.00 | ₹1.00 | ₹1.00 |
Share Warrants & Outstandings | - | - | - | - | ₹32 Cr |
Total Reserves | ₹836 Cr | ₹837 Cr | ₹871 Cr | ₹-235 Cr | ₹161 Cr |
Securities Premium | ₹92 Cr | ₹92 Cr | ₹92 Cr | ₹92 Cr | ₹92 Cr |
Capital Reserves | ₹-253 Cr | ₹-253 Cr | ₹-253 Cr | ₹-280 Cr | - |
Profit & Loss Account Balance | ₹788 Cr | ₹790 Cr | ₹825 Cr | ₹-254 Cr | ₹-108 Cr |
General Reserves | ₹79 Cr | ₹79 Cr | ₹79 Cr | ₹79 Cr | ₹47 Cr |
Other Reserves | ₹130 Cr | ₹130 Cr | ₹128 Cr | ₹128 Cr | ₹129 Cr |
Reserve excluding Revaluation Reserve | ₹836 Cr | ₹837 Cr | ₹871 Cr | ₹-235 Cr | ₹161 Cr |
Revaluation reserve | - | - | - | - | - |
Shareholder's Funds | ₹842 Cr | ₹844 Cr | ₹877 Cr | ₹-229 Cr | ₹199 Cr |
Minority Interest | ₹-3.82 Cr | ₹-3.49 Cr | ₹-2.98 Cr | ₹-3.00 Cr | ₹-3.04 Cr |
Long-Term Borrowings | - | - | - | - | - |
Secured Loans | - | ₹0.18 Cr | ₹0.24 Cr | ₹675 Cr | ₹584 Cr |
Non Convertible Debentures | - | - | - | ₹754 Cr | ₹699 Cr |
Converible Debentures & Bonds | - | - | - | - | - |
Packing Credit - Bank | - | - | - | - | - |
Inter Corporate & Security Deposit | - | - | - | - | - |
Term Loans - Banks | - | - | - | - | - |
Term Loans - Institutions | - | - | - | - | - |
Other Secured | - | ₹0.18 Cr | ₹0.24 Cr | ₹-79 Cr | ₹-116 Cr |
Unsecured Loans | ₹21 Cr | ₹20 Cr | ₹34 Cr | ₹60 Cr | ₹30 Cr |
Fixed Deposits - Public | - | - | - | - | - |
Loans and advances from subsidiaries | - | - | - | - | - |
Inter Corporate Deposits (Unsecured) | - | - | - | - | - |
Foreign Currency Convertible Notes | - | - | - | - | - |
Long Term Loan in Foreign Currency | - | - | - | - | - |
Loans - Banks | - | - | - | - | - |
Loans - Govt. | - | - | - | - | - |
Loans - Others | ₹15 Cr | ₹15 Cr | ₹30 Cr | ₹56 Cr | ₹27 Cr |
Other Unsecured Loan | ₹5.99 Cr | ₹4.98 Cr | ₹4.15 Cr | ₹3.65 Cr | ₹2.90 Cr |
Deferred Tax Assets / Liabilities | ₹23 Cr | ₹20 Cr | ₹-24 Cr | ₹-0.15 Cr | ₹-1.95 Cr |
Deferred Tax Assets | ₹77 Cr | ₹80 Cr | ₹127 Cr | ₹120 Cr | ₹136 Cr |
Deferred Tax Liability | ₹99 Cr | ₹100 Cr | ₹104 Cr | ₹120 Cr | ₹134 Cr |
Other Long Term Liabilities | ₹22 Cr | ₹32 Cr | ₹46 Cr | ₹194 Cr | ₹87 Cr |
Long Term Trade Payables | - | - | - | - | - |
Long Term Provisions | ₹199 Cr | ₹198 Cr | ₹29 Cr | ₹31 Cr | ₹43 Cr |
Total Non-Current Liabilities | ₹265 Cr | ₹271 Cr | ₹85 Cr | ₹960 Cr | ₹741 Cr |
Current Liabilities | - | - | - | - | - |
Trade Payables | ₹154 Cr | ₹177 Cr | ₹235 Cr | ₹247 Cr | ₹199 Cr |
Sundry Creditors | ₹154 Cr | ₹177 Cr | ₹235 Cr | ₹247 Cr | ₹199 Cr |
Acceptances | - | - | - | - | - |
Due to Subsidiaries- Trade Payables | - | - | - | - | - |
Other Current Liabilities | ₹119 Cr | ₹116 Cr | ₹503 Cr | ₹187 Cr | ₹242 Cr |
Bank Overdraft / Short term credit | - | - | - | - | - |
Advances received from customers | ₹78 Cr | ₹77 Cr | ₹172 Cr | ₹65 Cr | ₹15 Cr |
Interest Accrued But Not Due | - | ₹0.00 Cr | ₹4.51 Cr | ₹25 Cr | ₹48 Cr |
Share Application Money | - | - | - | - | - |
Current maturity of Debentures & Bonds | - | - | - | - | - |
Current maturity - Others | - | - | - | - | - |
Other Liabilities | ₹42 Cr | ₹39 Cr | ₹327 Cr | ₹98 Cr | ₹179 Cr |
Short Term Borrowings | - | - | - | - | ₹3.57 Cr |
Secured ST Loans repayable on Demands | - | - | - | - | - |
Working Capital Loans- Sec | - | - | - | - | - |
Buyers Credits - Unsec | - | - | - | - | - |
Commercial Borrowings- Unsec | - | - | - | - | ₹3.57 Cr |
Other Unsecured Loans | - | - | - | - | - |
Short Term Provisions | ₹36 Cr | ₹37 Cr | ₹36 Cr | ₹13 Cr | ₹178 Cr |
Proposed Equity Dividend | - | - | - | - | - |
Provision for Corporate Dividend Tax | - | - | - | - | - |
Provision for Tax | ₹0.14 Cr | ₹0.56 Cr | ₹0.09 Cr | ₹0.03 Cr | ₹171 Cr |
Provision for post retirement benefits | - | - | - | - | - |
Preference Dividend | - | - | - | - | - |
Other Provisions | ₹36 Cr | ₹36 Cr | ₹36 Cr | ₹13 Cr | ₹6.96 Cr |
Total Current Liabilities | ₹309 Cr | ₹330 Cr | ₹774 Cr | ₹447 Cr | ₹622 Cr |
Total Liabilities | ₹1,412 Cr | ₹1,443 Cr | ₹1,735 Cr | ₹1,177 Cr | ₹1,559 Cr |
ASSETS | |||||
Gross Block | ₹1,312 Cr | ₹1,331 Cr | ₹1,314 Cr | ₹1,266 Cr | ₹1,282 Cr |
Less: Accumulated Depreciation | ₹743 Cr | ₹731 Cr | ₹692 Cr | ₹658 Cr | ₹625 Cr |
Less: Impairment of Assets | - | - | - | - | - |
Net Block | ₹569 Cr | ₹600 Cr | ₹622 Cr | ₹609 Cr | ₹657 Cr |
Lease Adjustment A/c | - | - | - | - | - |
Capital Work in Progress | ₹75 Cr | ₹28 Cr | ₹4.91 Cr | ₹21 Cr | ₹9.51 Cr |
Non Current Investments | ₹0.07 Cr | ₹0.07 Cr | ₹0.07 Cr | ₹0.07 Cr | ₹5.58 Cr |
Long Term Investment | ₹0.07 Cr | ₹0.07 Cr | ₹0.07 Cr | ₹0.07 Cr | ₹5.58 Cr |
Quoted | - | - | - | - | - |
Unquoted | ₹0.07 Cr | ₹0.07 Cr | ₹0.07 Cr | ₹0.07 Cr | ₹5.58 Cr |
Long Term Loans & Advances | ₹242 Cr | ₹228 Cr | ₹21 Cr | ₹18 Cr | ₹188 Cr |
Other Non Current Assets | ₹1.11 Cr | ₹3.74 Cr | ₹84 Cr | ₹5.61 Cr | ₹0.60 Cr |
Total Non-Current Assets | ₹927 Cr | ₹874 Cr | ₹745 Cr | ₹666 Cr | ₹875 Cr |
Current Assets Loans & Advances | - | - | - | - | - |
Currents Investments | ₹40 Cr | ₹13 Cr | ₹5.00 Cr | - | - |
Quoted | ₹40 Cr | ₹13 Cr | ₹5.00 Cr | - | - |
Unquoted | - | - | - | - | - |
Inventories | ₹178 Cr | ₹202 Cr | ₹213 Cr | ₹174 Cr | ₹148 Cr |
Raw Materials | ₹99 Cr | ₹101 Cr | ₹84 Cr | ₹87 Cr | ₹66 Cr |
Work-in Progress | ₹17 Cr | ₹16 Cr | ₹31 Cr | ₹18 Cr | ₹21 Cr |
Finished Goods | ₹43 Cr | ₹55 Cr | ₹77 Cr | ₹44 Cr | ₹48 Cr |
Packing Materials | - | - | - | - | - |
Stores  and Spare | ₹15 Cr | ₹19 Cr | ₹12 Cr | ₹20 Cr | ₹8.80 Cr |
Other Inventory | ₹3.93 Cr | ₹10 Cr | ₹8.81 Cr | ₹5.92 Cr | ₹3.73 Cr |
Sundry Debtors | ₹57 Cr | ₹60 Cr | ₹82 Cr | ₹85 Cr | ₹69 Cr |
Debtors more than Six months | ₹8.60 Cr | ₹7.65 Cr | ₹23 Cr | ₹28 Cr | - |
Debtors Others | ₹53 Cr | ₹57 Cr | ₹63 Cr | ₹61 Cr | ₹71 Cr |
Cash and Bank | ₹139 Cr | ₹226 Cr | ₹583 Cr | ₹136 Cr | ₹90 Cr |
Cash in hand | ₹0.04 Cr | ₹0.05 Cr | ₹0.06 Cr | ₹0.07 Cr | ₹0.08 Cr |
Balances at Bank | ₹139 Cr | ₹226 Cr | ₹583 Cr | ₹136 Cr | ₹90 Cr |
Other cash and bank balances | - | - | - | - | - |
Other Current Assets | ₹12 Cr | ₹8.41 Cr | ₹8.75 Cr | ₹16 Cr | ₹336 Cr |
Interest accrued on Investments | - | - | - | - | - |
Interest accrued on Debentures | - | - | - | - | - |
Deposits with Government | - | - | - | - | - |
Interest accrued and or due on loans | - | - | - | - | - |
Prepaid Expenses | ₹6.06 Cr | ₹5.22 Cr | ₹5.35 Cr | ₹5.29 Cr | ₹5.65 Cr |
Other current_assets | ₹5.91 Cr | ₹3.19 Cr | ₹3.40 Cr | ₹11 Cr | ₹330 Cr |
Short Term Loans and Advances | ₹58 Cr | ₹52 Cr | ₹59 Cr | ₹64 Cr | ₹42 Cr |
Advances recoverable in cash or in kind | ₹4.80 Cr | ₹3.51 Cr | ₹6.30 Cr | ₹14 Cr | ₹16 Cr |
Advance income tax and TDS | - | - | - | - | - |
Amounts due from directors | - | - | - | - | - |
Due From Subsidiaries | - | - | - | - | - |
Inter corporate deposits | - | - | - | - | - |
Corporate Deposits | - | - | - | - | - |
Other Loans & Advances | ₹53 Cr | ₹49 Cr | ₹53 Cr | ₹50 Cr | ₹26 Cr |
Total Current Assets | ₹485 Cr | ₹562 Cr | ₹951 Cr | ₹474 Cr | ₹683 Cr |
Net Current Assets (Including Current Investments) | ₹176 Cr | ₹233 Cr | ₹177 Cr | ₹27 Cr | ₹61 Cr |
Miscellaneous Expenses not written off | - | - | - | - | - |
Total Assets | ₹1,412 Cr | ₹1,443 Cr | ₹1,735 Cr | ₹1,177 Cr | ₹1,559 Cr |
Contingent Liabilities | ₹369 Cr | ₹656 Cr | ₹368 Cr | ₹407 Cr | ₹367 Cr |
Total Debt | ₹21 Cr | ₹20 Cr | ₹34 Cr | ₹820 Cr | ₹742 Cr |
Book Value | 137.48 | 137.73 | 143.12 | -37.34 | 27.23 |
Adjusted Book Value | 137.48 | 137.73 | 143.12 | -37.34 | 27.23 |
Compare Balance Sheet of peers of PANACEA BIOTEC
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
PANACEA BIOTEC | ₹2,542.4 Cr | 16.2% | 14.3% | 141.4% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹426,518.0 Cr | -1.4% | -7.1% | 48% | Stock Analytics | |
DIVIS LABORATORIES | ₹158,636.0 Cr | 1.5% | -2.1% | 63% | Stock Analytics | |
CIPLA | ₹118,368.0 Cr | -3.5% | -5.2% | 18% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹99,671.4 Cr | -3.9% | -10.1% | 10.1% | Stock Analytics | |
ZYDUS LIFESCIENCES | ₹95,013.6 Cr | -0.3% | -7.3% | 52.2% | Stock Analytics |
PANACEA BIOTEC Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
PANACEA BIOTEC | 16.2% |
14.3% |
141.4% |
SENSEX | -1.9% |
-5% |
17.5% |
You may also like the below Video Courses